| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
RILMENIDINE HEMIFUMARATE SALT manufacturers
|
| | RILMENIDINE HEMIFUMARATE SALT Basic information |
| Product Name: | RILMENIDINE HEMIFUMARATE SALT | | Synonyms: | RILMENIDINE HEMIFUMARATE SALT;n-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt;Oxaminozoline hemifumarate salt, Rilmenidene hemifumarate salt, N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt;LZFATBMLSYHRTC-WXXKFALUSA-N;N-(dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine hemifumarate | | CAS: | 207572-68-7 | | MF: | 2C10H16N2O.C4H4O4 | | MW: | 476.57 | | EINECS: | | | Product Categories: | | | Mol File: | 207572-68-7.mol |  |
| | RILMENIDINE HEMIFUMARATE SALT Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: >10mg/mL | | form | solid | | color | white | | InChI | 1S/2C10H16N2O.C4H4O4/c2*1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10;5-3(6)1-2-4(7)8/h2*7-9H,1-6H2,(H,11,12);1-2H,(H,5,6)(H,7,8)/b;;2-1+ | | InChIKey | LZFATBMLSYHRTC-WXXKFALUSA-N | | SMILES | OC(=O)\C=C\C(O)=O.C1CN=C(NC(C2CC2)C3CC3)O1.C4CN=C(NC(C5CC5)C6CC6)O4 |
| Safety Statements | 22-24/25 | | WGK Germany | 3 | | RTECS | RP7207400 | | Storage Class | 11 - Combustible Solids |
| | RILMENIDINE HEMIFUMARATE SALT Usage And Synthesis |
| Uses | Rilmenidine hemifumarate ┬аis an antihypertensive agent that selectively binds nonadrenergic imidazoline-binding site I1 receptor. | | Biological Activity | rilmenidine is an antihypertensive agent that has been shown to lower arterial pressure in various animal models by inhibiting the tonic activity of sympathoexcitatory neurons in the rostral ventrolateral medulla [1]. | | Biochem/physiol Actions | Selective I1 imidazoline receptor agonist. | | in vitro | bilateral microinjection of rilmenidine into the c1 area of the rostral ventrolateral medulla (rvl) elicited dose-dependent falls in arterial pressure and heart rate. in rvl, rilmenidine competed with binding to imidazole and α2-adrenergic binding sites with a 30-fold selectivity for the imidazole binding sites [2]. rilmenidine, a new antihypertensive agent, appeared 2.5 and 3.5 times more selective than clonidine and guanfacine, respectively, for medullary ipr sites than for cortical α-adrenoceptors [3]. rilmenidine targeted the nonadrenergic imidazoline-binding site i1 receptor with the ki value of 7.1 nm and demonstrated weaker affinity for the i2 receptor with the ki value of 5.2 μm [4]. | | in vivo | in rat model of hypertension associated with insulin resistance, rilmenidine ameliorated the deleterious effects of a high-fructose diet, such as weight gain, hypertension, and resistance to the effects of insulin [5]. in a mouse model of huntington's disease, rilmenidine induced autophagy, attenuated toxicity of polyglutamine expansions and the signs of disease, reduced the mutant huntingtin fragment levels [6]. | | storage | Store at -20°C | | references | [1] reis, d. j. and piletz, j.e. the imidazoline receptor in control of blood pressure by clonidine and allied drugs. american journal of physiology 273(5 pt 2), r1569-r1571 (1997).
[2] gomez r e, ernsberger p, feinland g, et al. rilmenidine lowers arterial pressure via imidazole receptors in brainstem c1 area[j]. european journal of pharmacology, 1991, 195(2): 181-191.
[3] bricca g, dontenwill m, molines a, et al. rilmenidine selectivity for imidazoline receptors in human brain[j]. european journal of pharmacology, 1989, 163(2): 373-377.
[4] guyenet p g. is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites [j]. american journal of physiology-regulatory, integrative and comparative physiology, 1997, 273(5): r1580-r1584.
[5] penicaud l, berthault m f, morin j, et al. rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats[j]. journal of hypertension. supplement: official journal of the international society of hypertension, 1998, 16(3): s45-9.
[6] rose c, menzies f m, renna m, et al. rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of huntington's disease[j]. human molecular genetics, 2010, 19(11): 2144-2153. |
| | RILMENIDINE HEMIFUMARATE SALT Preparation Products And Raw materials |
|